Close
ACHEMA MIDDLE EAST 2026

FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

The US FDA approves Sanofi’s Wayrilz (rilzabrutinib) for use in adult patients with chronic or persistent immune thrombocytopenia (ITP) who did not respond adequately...

U.S. FDA Approves Ionis’ DAWNZERA for Hereditary Angioedema

Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted approval for DAWNZERA™ (donidalorsen). The treatment is approved for prophylaxis to...

Roche’s Genentech Launches New Manufacturing Facility in USA

Genentech, part of the Roche Group, has broken ground on its latest US manufacturing facility in Holly Springs, North Carolina. The development represents the...

J&J Investment of $2B Boosts US Drug Manufacturing Capacity

Johnson & Johnson, an industry leader known for its global healthcare innovation, unveiled plans to increase its presence in the state of North Carolina...

Pharmaceutical Tariff Agreed at 15% Under US-EU Trade Deal

Pharmaceutical tariffs between the European Union and the United States will now be limited at 15% under the terms of the latest trade agreement,...

The U.S. FDA Approved Papzimeos for RRP Treatment in Adults

The U.S. Food and Drug Administration granted approval for Papzimeos (zopapogene imadenovec-drba), marking the introduction of a first-of-its-kind, non-replicating adenoviral vector-based immunotherapy for adult...

Trump Signs Executive Order to Boost US Pharma Supply Chain

US President Donald Trump has instructed the Department of Health and Human Services (HHS) to compile a list of essential medicines and ensure the...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...